循環器内科学

Medicine & Life Sciences

1. Acute Coronary Syndrome 56%
2. Acute Kidney Injury 13%
3. Angiography 12%
4. Angiotensin Receptor Antagonists 11%
5. Anticoagulants 17%
6. Atherosclerosis 11%
7. Atherosclerotic Plaques 26%
8. Atorvastatin 19%
9. Atrial Fibrillation 70%
10. Biomarkers 13%
11. Blood Vessels 12%
12. Brain Natriuretic Peptide 38%
13. Cardiac Rehabilitation 14%
14. Cardiac Resynchronization Therapy 10%
15. Cardiogenic Shock 11%
16. Cardiology 17%
17. Catheter Ablation 10%
18. Cause of Death 11%
19. Chronic Renal Insufficiency 21%
20. Cohort Studies 10%
21. Computed Tomography Angiography 46%
22. Confidence Intervals 20%
23. Coronary Angiography 37%
24. Coronary Artery Disease 70%
25. Coronary Stenosis 12%
26. Coronary Vessels 34%
27. Coronavirus 18%
28. Dilated Cardiomyopathy 11%
29. Drug-Eluting Stents 12%
30. Echocardiography 29%
31. Eicosapentaenoic Acid 18%
32. Elderly 12%
33. Electrocardiography 10%
34. Equipment and Supplies 14%
35. Everolimus 20%
36. Exercise 16%
37. Extracorporeal Membrane Oxygenation 17%
38. Fatty Acid-Binding Proteins 9%
39. Frailty 11%
40. Glomerular Filtration Rate 18%
41. Heart 21%
42. Heart Diseases 10%
43. Heart Failure 100%
44. Heart Transplantation 22%
45. Heart-Assist Devices 39%
46. Hemorrhage 24%
47. Hospital Mortality 14%
48. Hospitalization 9%
49. Hydroxymethylglutaryl-CoA Reductase Inhibitors 41%
50. Hypertrophic Cardiomyopathy 10%
51. Incidence 17%
52. iodofiltic acid 11%
53. Japan 42%
54. LDL Cholesterol 16%
55. Left Ventricular Dysfunction 16%
56. Left Ventricular Function 9%
57. Lipids 26%
58. Mortality 21%
59. Multicenter Studies 13%
60. Myocardial Infarction 87%
61. Myocardial Perfusion Imaging 25%
62. Myocarditis 31%
63. Non-ST Elevated Myocardial Infarction 20%
64. Optical Coherence Tomography 41%
65. Pandemics 10%
66. Pathologic Constriction 18%
67. pentadecanoic acid 9%
68. Percutaneous Coronary Intervention 70%
69. Perfusion 16%
70. Peripheral Arterial Disease 9%
71. pitavastatin 50%
72. Population 10%
73. Pressure 11%
74. Prospective Studies 9%
75. Registries 28%
76. Regression Analysis 11%
77. Rivaroxaban 18%
78. ROC Curve 11%
79. Safety 15%
80. Sarcoidosis 13%
81. Secondary Prevention 10%
82. Serum 14%
83. Single-Photon Emission-Computed Tomography 12%
84. Sirolimus 16%
85. ST Elevation Myocardial Infarction 20%
86. Stable Angina 11%
87. Stents 55%
88. Stroke 13%
89. Stroke Volume 23%
90. Subarachnoid Hemorrhage 13%
91. Tachycardia 9%
92. Therapeutics 23%
93. Thrombosis 19%
94. Tomography 18%
95. Transcatheter Aortic Valve Replacement 9%
96. Transplants 15%
97. Troponin 12%
98. Troponin I 11%
99. Unstable Angina 15%
100. Warfarin 14%